June 19, 2018 – Amaranth Medical offered new details about its 85-micron Defiance bioresorbable scaffold (BRS) recently at...
Stents Bioresorbable
This channel includes news and new technology innovations for bioresorbable stents. These devices are also referred to as bioabsorbable stents, bioresorbable scaffolds and dissolving stents.
-
-
There was no shortage of interest in bioresorbable stent technologies at the many sessions offered on this topic or based on the number of start-up bioresorbable stent companies presenting at the...
-
A discussion with Ajay Kirtane, M.D., SM, director of the cardiac catheterization laboratories at New York-Presbyterian Hospital/Columbia University Medical Center, on the ABSORB III 3-year...
-
October 31, 2017 — The U.S.
Feature | Stents Bioresorbable | June 19, 2018
June 19, 2018 – Amaranth Medical offered new details about its 85-micron Defiance bioresorbable scaffold (BRS)...
Image courtesy of Hexacath
News | Stents Drug Eluting | May 31, 2018
May 31, 2018 – Late-breaking...
News | Stents | January 25, 2018
January 25, 2018 – Elixir Medical Corporation, a leader in the development of breakthrough adaptive remodeling...
The Abbott Absorb Bioresorbable Vascular Scaffold (BVS).
Feature | Stents Drug Eluting | January 17, 2018 | Dave Fornell
There was no shortage of interest in bioresorbable stent technologies at the many sessions offered on this topic or...
OCT comparison between the Combo vs. Xience stents in the HARMONEE study.
Feature | Stents | November 08, 2017
November 8, 2017 – New results from the HARMONEE Japan/U.S. Registration Trial, reported by in a first report...
Videos | Stents Bioresorbable | November 07, 2017
A discussion with Ajay Kirtane, M.D., SM, director of the cardiac catheterization laboratories at New York-...
News | Stents Bioresorbable | October 31, 2017
October 31, 2017 – Thirty-day results from ABSORB IV, the largest randomized everolimus-eluting...
News | Stents Bioresorbable | October 31, 2017
October 31, 2017 — The U.S. Food and Drug Administration (FDA) issued a warning to healthcare providers that interim...
News | Stents Bioresorbable | October 25, 2017
October 25, 2017 — Amaranth Medical will provide an update at the annual Transcatheter Cardiovascular Therapeutics (...
Feature | Stents Bioresorbable | September 08, 2017 | Dave Fornell
September 8, 2017 — Abbott Vascular has announced it will end commercial sales of its Absorb bioresorbable vascular...
Videos | Stents Bioresorbable | March 30, 2017
Stephen Ellis, M.D., professor of medicine and director of interventional cardiology at Cleveland Clinic, discusses...
Feature | Stents Bioresorbable | March 21, 2017 | Dave Fornell
March 21, 2017 — In the late-breaking ABSORB III Trial two year results presented at the American College of...
Blog | Stents | February 13, 2017
Stents were the key focus of interventional cardiology for more than 20 years, but the focus has changed in recent...
Blog | January 30, 2017
DAIC has worked hard to bring useful technology news and resources to our readers. While we conduct reader surveys...
The Synergy stent is the first FDA cleared drug-eluting stent to use a bioresorbable polymer drug carrier. When the polymer dissolves after about four months, the devices become a bare metal stent. The technology is supposed to reduce the rate of late stent thrombosis due to vessel inflammation caused by durable polymers.
Feature | Stents Bioresorbable | January 17, 2017 | Dave Fornell
One of the big advancements in drug-eluting stent (DES) technology has been the development of bioresorbable...
